Eloxx Pharmaceuticals Inc ELOX:OTCPK

*Data is delayed | Exchange | USD
Last | 05/03/24 EDT
0.90quote price arrow up+0.05 (+5.8824%)
Volume
1,651
52 week range
0.40 - 10.90
Loading...
  • Open0.895
  • Day High0.90
  • Day Low0.85
  • Prev Close0.85
  • 52 Week High10.90
  • 52 Week High Date05/15/23
  • 52 Week Low0.40
  • 52 Week Low Date12/14/23

Key Stats

  • Market Cap2.829M
  • Shares Out3.14M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change-25

KEY STATS

  • Open0.895
  • Day High0.90
  • Day Low0.85
  • Prev Close0.85
  • 52 Week High10.90
  • 52 Week High Date05/15/23
  • 52 Week Low0.40
  • 52 Week Low Date12/14/23
  • Market Cap2.829M
  • Shares Out3.14M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change-25

RATIOS/PROFITABILITY

  • EPS (TTM)-9.06
  • P/E (TTM)-0.10
  • Fwd P/E (NTM)-0.74
  • EBITDA (TTM)-19.238M
  • ROE (TTM)-615.23%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-27.13%

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eloxx Pharmaceuticals Inc

 

Profile

MORE
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule...
Sumit Aggarwal
President, Chief Executive Officer, Director
Daniel Geffken CPA
Interim Chief Financial Officer
Address
480 ARSENAL WAY, SUITE 130
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
REVB
Revelation Biosciences Inc
2.36+0.01+0.43%
SLRX
Salarius Pharmaceuticals Inc
0.501-0.0266-5.0417%
GLMD
Galmed Pharmaceuticals Ltd
0.384-0.0011-0.2856%
CNSP
CNS Pharmaceuticals Inc
0.2211+0.0056+2.59%
DRMA
Dermata Therapeutics Inc
0.336-0.0041-1.2055%